Products

Solutions

21 CFR 211.198 - Complaint Files

Overview:

21 CFR 211.198 outlines requirements for handling and documenting complaints related to drug products, ensuring proper investigation and resolution. 

It mandates establishing written procedures for reviewing complaints, determining if investigations are needed, and maintaining complaint records for a specified period. 

This regulation is crucial for pharmaceutical manufacturers, quality control teams, and compliance officers to ensure the safety and efficacy of drug products and compliance with FDA guidelines.

(a) 

Written procedures describing the handling of all written and oral complaints regarding a drug product shall be established and followed. Such procedures shall include provisions for review by the quality control unit, of any complaint involving the possible failure of a drug product to meet any of its specifications and, for such drug products, a determination as to the need for an investigation in accordance with § 211.192. Such procedures shall include provisions for review to determine whether the complaint represents a serious and unexpected adverse drug experience which is required to be reported to the Food and Drug Administration in accordance with §§ 310.305 and 514.80 of this chapter.

(b) 

A written record of each complaint shall be maintained in a file designated for drug product complaints. The file regarding such drug product complaints shall be maintained at the establishment where the drug product involved was manufactured, processed, or packed, or such file may be maintained at another facility if the written records in such files are readily available for inspection at that other facility. Written records involving a drug product shall be maintained until at least 1 year after the expiration date of the drug product, or 1 year after the date that the complaint was received, whichever is longer. In the case of certain OTC drug products lacking expiration dating because they meet the criteria for exemption under § 211.137, such written records shall be maintained for 3 years after distribution of the drug product.

(1) The written record shall include the following information, where known: the name and strength of the drug product, lot number, name of complainant, nature of complaint, and reply to complainant.

(2) Where an investigation under § 211.192 is conducted, the written record shall include the findings of the investigation and followup. The record or copy of the record of the investigation shall be maintained at the establishment where the investigation occurred in accordance with § 211.180(c).

Compliance AI Agents

for consumer products

Signify helps regulatory and product compliance teams in CPG and durables manufacturing launch products faster by automating global compliance.

Signify is the leading compliance system for consumer products—leveraging AI agents to automate gap analysis, streamline conformity checks, and accelerate safe, high-quality product launches.

Company

About Us

Terms of Service

Privacy Policy

DPA

Resources

Blog

Guides

Why Now

21 CFR

Use Cases

Supplier Check

Labeling

Internal Audits

Quality & Safety

Import & Export

Signify SOC2 Type 2 Compliant

© 2025 Signify Technologies, Corp.

Compliance AI Agents

for consumer products

Signify helps regulatory and product compliance teams in CPG and durables manufacturing launch products faster by automating global compliance.

Signify is the leading compliance system for consumer products—leveraging AI agents to automate gap analysis, streamline conformity checks, and accelerate safe, high-quality product launches.

Company

About Us

Terms of Service

Privacy Policy

DPA

Resources

Blog

Guides

Why Now

21 CFR

Use Cases

Supplier Check

Labeling

Internal Audits

Quality & Safety

Import & Export

Signify SOC2 Type 2 Compliant

© 2025 Signify Technologies, Corp.

Compliance AI Agents

for consumer products

Signify helps regulatory and product compliance teams in CPG and durables manufacturing launch products faster by automating global compliance.

Signify is the leading compliance system for consumer products—leveraging AI agents to automate gap analysis, streamline conformity checks, and accelerate safe, high-quality product launches.

Signify SOC2 Type 2 Compliant

© 2025 Signify Technologies, Corp.

Use Cases

Supplier Check

Labeling

Internal Audits

Quality & Safety

Import & Export

Resources

Blog

Guides

Why Now

21 CFR

Company

About Us

Terms of Service

Privacy Policy

DPA

Compliance AI Agents

for consumer products

Signify helps regulatory and product compliance teams in CPG and durables manufacturing launch products faster by automating global compliance.

Signify is the leading compliance system for consumer products—leveraging AI agents to automate gap analysis, streamline conformity checks, and accelerate safe, high-quality product launches.

Use Cases

Supplier Check

Labeling

Internal Audits

Quality & Safety

Import & Export

Resources

Blog

Guides

Why Now

21 CFR

Company

About Us

Terms of Service

Privacy Policy

DPA

Signify SOC2 Type 2 Compliant

© 2025 Signify Technologies, Corp.